Matt Hurd and Krishna Veeraraghavan Named Dealmakers of the Week by The American Lawyer

May 8, 2015

On May 8, The American Lawyer named Messrs. Hurd and Veeraraghavan as Dealmakers of the Week for their role advising Synageva BioPharma in its $9 billion acquisition by Alexion Pharmaceuticals. AmLaw reports that the deal will provide Alexion with ownership of Synageva's drug Kanuma, which is awaiting approval from the US FDA for treatment of a rare disease. For Messrs. Hurd and Veeraraghavan, who have been advising Synageva for the past two years, the life sciences industry is fascinating.